Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomedicines|February 25, 2022
Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular CarcinomaJiyan Wang, Yaya Qiao, Huanran Sun, et al.
International Journal of Molecular Sciences|May 14, 2022
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell CarcinomaJiyan Wang, Hongkai Chang, Meng Su, et al.
Frontiers in Pharmacology|July 11, 2022
The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network PharmacologyJiyan Wang, Hongkai Chang, Meng Su, et al.
Expert Opinion on Therapeutic Targets|August 12, 2023
Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancerChenxi Wang, Chenxi Yu, Hongkai Chang, et al.
Cancers|July 27, 2022
PRIM2 Promotes Cell Cycle and Tumor Progression in p53-Mutant Lung CancerTaoyuan Wang, Tiansheng Tang, Youguo Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 29, 2025
HPD is an m<sup>6</sup>A Methyltransferase that Protects Colorectal Cancer Cells from Ferroptotic Cell Death by m<sup>6</sup>A Methylating SLC7A11/GPX4Jiyan Wang, Xintong Dai, Huanle Liu, et al.
Medcomm|March 31, 2023
PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1Fei Xie, Han Zhang, Kongkai Zhu, et al.
Acta Pharmaceutica Sinica. B|February 23, 2023
PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolismMingming Sun, Leilei Li, Yujia Niu, et al.
Pageof 1